Coronavirus weekly round-up: Oil prices turn negative while a leading Covid-19 vaccine trial disappoints
Five investors mull the events shaping portfolios over the past week
Five investors mull the events shaping portfolios over the past week
|
|
WTI contracts hit by ‘double whammy’ of supply glut and coronavirus lockdown
|
|
Repsol was once named among the world’s worst greenhouse gas emitters
|
|
BP and Glencore changes could be instrumental in bringing more information to investors
|
|
Invesco UK equities manager comes out swinging for UK stocks, oil and tobacco
|
|
The oil and gas majors best positioned for a low-carbon future
|
|
Funds investing in oil, healthcare and US smaller companies led the way in the third quarter
|
|
Climate change has landed oil majors offside with a number of investors representing $10.4trn worth of assets ahead of their annual general meetings (AGMs) over the next couple of weeks.
|
|
Nick Train has said he will not be drawn into investing in oil majors despite the bumper returns they have delivered for his investment trust’s FTSE All Share benchmark.
|
|
Donald Trump’s decision to walk away from the Iran nuclear deal has seen the oil price take off, as political tensions in the Middle East look set to increase.
|
|
Brent crude oil slipped to a one-month low as the International Energy Agency (IEA) warned that increasing US production could jeopardise the oil price recovery.
|
|
A fall in oil and gas production may see below consensus GDP growth of 0.3% for the fourth quarter of 2017, despite bullish business surveys, consultancy Pantheon Economics says.
|
|